The plasma level of Hsp90α was significantly higher in patients with liver cancer (200.58 ± 143.64 ng/mL) than in patients with benign tumors (110.64 ± 90.06 ng/mL) and healthy controls (35.07 ± 15.42 ng/mL). This evidence concerns the gene HSP90AA1 and benign neoplasm.